Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing (September 2020)

KE Hanson, AM Caliendo, CA Arias… - Clinical Infectious …, 2024 - academic.oup.com
Background The availability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) serologic testing has rapidly increased. Current assays use a variety of technologies …

Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis

HR Savage, VS Santos, T Edwards… - PLoS neglected …, 2021 - journals.plos.org
Background Individuals infected with SARS-CoV-2 develop neutralising antibodies. We
investigated the proportion of individuals with SARS-CoV-2 neutralising antibodies after …

A systematic review and meta-analysis of the accuracy of SARS-COV-2 IGM and IGG tests in individuals with COVID-19

ACL Macedo, G da Silveira Prestes, T Colonetti… - Journal of Clinical …, 2022 - Elsevier
Abstract Introduction: Active SARS-CoV-2 infection is confirmed mainly through the detection
of viral nucleic acid via the reverse transcriptase polymerase chain reaction (RT-PCR) …

Diagnostic efficiency of three fully automated serology assays and their correlation with a novel surrogate virus neutralization test in symptomatic and asymptomatic …

S Younes, H Al-Jighefee, F Shurrab, DW Al-Sadeq… - Microorganisms, 2021 - mdpi.com
To support the deployment of serology assays for population screening during the COVID-
19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG …

Evaluation of antibody response in symptomatic and asymptomatic COVID-19 patients and diagnostic assessment of new IgM/IgG ELISA kits

HT Al-Jighefee, HM Yassine, MA Al-Nesf, AA Hssain… - Pathogens, 2021 - mdpi.com
This study aims to study the immune response and evaluate the performances of four new
IgM and five IgG enzyme-linked immunosorbent assay (ELISA) kits for detecting anti-severe …

[HTML][HTML] Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD …

FM Shurrab, N Younes, DW Al-Sadeq, N Liu… - International Journal of …, 2022 - Elsevier
Background A vast majority of the commercially available lateral flow immunoassay (LFIA) is
used to detect SARS-CoV-2 antibodies qualitatively. Recently, a novel fluorescence-based …

Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population

GK Nasrallah, SR Dargham, F Shurrab, DW Al-Sadeq… - Scientific reports, 2021 - nature.com
Performance of three automated commercial serological IgG-based assays was investigated
for assessing SARS-CoV-2 “ever”(past or current) infection in a population-based sample in …

Current diagnostic approaches to detect two important betacoronaviruses: Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory …

ZX Chong, WPP Liew, HK Ong, CY Yong… - … -Research and Practice, 2021 - Elsevier
Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are two common betacoronaviruses, which are still …

Immunological tests: Essential and supportive tools in the fight against COVID-19

D Zhang, D Kukkar, KH Kim - TrAC Trends in Analytical Chemistry, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has spread globally since December 2019
and has generated distinctive spikes in death counts. To effectively control the viral spread …

[HTML][HTML] Serological surveillance of healthcare workers to evaluate natural infection-and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor …

P Arkell, C Gusmao, SL Sheridan, MY Tanesi… - International Journal of …, 2022 - Elsevier
Background Serosurveillance can be used to investigate the extent and distribution of
immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within a …